Results 31 to 40 of about 289,464 (193)

Cost-utility analysis of nonalcoholic steatohepatitis screening [PDF]

European Radiology, 2015
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. No studies have examined the cost-effectiveness of screening its advanced form, nonalcoholic steatohepatitis (NASH).We performed a cost-utility analysis of annual noninvasive screening strategies using third-party payer perspective in a general population in
Eric, Zhang, Claire, Wartelle-Bladou, Luigi, Lepanto, Jean, Lachaine, Guy, Cloutier, An, Tang   +5 more
openaire   +2 more sources

Immunization against Haemophilus influenzae type b in Iran; Cost-utility and cost-benefit analyses

International Journal of Preventive Medicine, 2012
Background: Haemophilus Influenzae type b (Hib) is an important cause of morbidity and mortality in children. Although its burden is considerably preventable by vaccine, routine vaccination against Hib has not been defined in the National Immunization ...
Maziar Moradi-Lakeh, Sareh Shakerian, Abdoulreza Esteghamati   +2 more
doaj  

Economic evaluation of vaccination against COVID‐19: A systematic review

Health Science Reports
Background and Aims Coronavirus has burdened considerable expenditures on the different health systems. Vaccination programs, the critical solution against pandemic diseases, are known as safe and effective interventions to prevent and control epidemics.
Dolatshahi Zeinab, Nargesi Shahin, Mezginejad Fateme, Bagheri Faradonbeh Saeed   +3 more
doaj   +1 more source

Alzheimer’s dementia: budget impact and cost-utility analysis of a combination treatment with a cholinesterase inhibitor and memantine in Switzerland

Swiss Medical Weekly, 2012
QUESTIONS UNDER STUDY: The objective of this study was to estimate the potential budget impact and cost-effectiveness of the combination treatment of a cholinesterase inhibitor and memantine in Switzerland.
Alena M. Pfeil, Reto W. Kressig, Thomas D. Szucs   +2 more
doaj   +1 more source

Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt

Human Vaccines & Immunotherapeutics, 2022
New vaccine introductions (NVIs) raise issues of value for money (VfM) for self-financing middle-income countries like Egypt. We evaluate a pediatric pneumococcal conjugate vaccine (PCV) NVI in Egypt from health payer and societal perspectives, using ...
JP Sevilla, Daria Burnes, Rehab Zakaria El Saie, Hammam Haridy, Matt Wasserman, Sarah Pugh, Johnna Perdrizet, David Bloom   +7 more
doaj   +1 more source

Standardizing cost-utility analysis in neurosurgery

Neurosurgical Focus, 2012
This review seeks to introduce the concept of cost-utility analysis in neurosurgery and to highlight its essential components. It also includes a suggested approach to standardization, which would help bring more credence to this research and potentially affect management choices, reimbursement, and policy.
Jared D, Ament, Kee D, Kim
openaire   +2 more sources

Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain [PDF]

Farmacia Hospitalaria, 2017
Objective: Fixed-dose combinations of antiretroviral drugs have meant an important step forward in simplifying treatment and improving compliance and has led to an increased effectiveness of therapy, a viral load decrease and improving the quality of ...
Santiago Moreno Guillen, Juan Emilio Losa García, Juan Berenguer Berenguer, José Manuel Martínez Sesmero, Santiago Cenoz Gomis, Ruth Graefenhain, David Lopez Sanchez-Cambronero, Francisco Javier Parrondo Garcia   +7 more
doaj   +1 more source

Single-chamber pacemakers: with or without leads? Cost-effectiveness and cost-utility analyses

Annals of Medicine
Introduction The evolution in pacemaker technologies has led to improvements in size, weight, functionality, and durability, even as the battery and electrode-based structural configuration has remained essentially the same.Objective To compare the cost ...
José Ramón Lago-Quinteiro, Francisco Reyes-Santias, Manel Antelo, Vicent Caballer-Tarazona, José Luis Martinez-Sande, Javier Garcia-Seara, Moisés Rodriguez-Manero, Jose Ramon Gonzalez-Juanatey   +7 more
doaj   +1 more source

Cost-Utility Analysis of Glaucoma Medication Adherence

Ophthalmology, 2020
The majority of patients with glaucoma do not take their medications as prescribed. Estimates of the cost-utility value of adherence to prescribed glaucoma medication are vital to implement potentially effective interventions.Cost-utility analysis using Monte Carlo microsimulations incorporating a series of Markov cycles (10 000 iterations per strategy)
Paula Anne Newman-Casey, Mariam Salman, Paul P. Lee, Justin D. Gatwood   +3 more
openaire   +3 more sources

Trastuzumab beyond progression: a cost-utility analysis [PDF]

Annals of Oncology, 2010
The continuation of trastuzumab beyond progression in combination with capecitabine as secondary chemotherapy for HER2-positive metastatic breast cancer (MBC) prolongs progression-free survival without a substantial increase in toxicity.A Markov cohort simulation was used to follow the clinical course of typical patients with MBC.
Matter-Walstra, K. W., Dedes, K. J., Schwenkglenks, M., Brauchli, P., Szucs, T. D., Pestalozzi, B. C.   +5 more
openaire   +4 more sources